• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, January 23, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

University of Alberta virologist awarded Nobel Prize in Physiology or Medicine

Bioengineer by Bioengineer
October 5, 2020
in Immunology
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Michael Houghton discovered hepatitis C virus and now is developing a vaccine

IMAGE

Credit: Photo: Michael Holly

Michael Houghton was awarded the 2020 Nobel Prize in Physiology or Medicine today in recognition of his discovery of the hepatitis C (HCV) virus.

His discovery with colleagues Qui-Lim Choo and George Kuo in 1989 opened a new field of viral hepatitis research that led to improved blood safety, and hepatitis C treatment to the point where the viral infection can now be cured in virtually all patients.

New screening tests were developed for blood donations as a result of their discovery. By 1992, the virus was virtually eliminated from the blood supply. This, in turn, led to a reduction in annual reported transmission by more than 80 per cent by 1996.

Houghton was recruited to the University of Alberta in 2010 as the Canada Excellence Research Chair in Virology in the Li Ka Shing Institute of Virology. Two years later, he and his team created hope with the development of a vaccine for the virus that is known to cause cirrhosis, end-stage liver disease and liver cancer. About 20 to 30 per cent of people who suffer from hepatitis C develop severe liver disease. The vaccine is now in the late pre-clinical stage of testing.

Based on the discovery of the virus, antiviral therapies have also been developed that will cure 95 per cent of hepatitis C carriers. This is the first chronic viral illness that can be cured.

Houghton recently began leading an effort to produce a vaccine for COVID-19. He had also created a successful vaccine for the SARS-CoV-1 virus in 2004, but it was never needed because SARS disappeared.

“Michael Houghton’s achievement cannot be overstated,” said University of Alberta president Bill Flanagan. “Dr. Houghton has made this world a better place. As president of the University of Alberta, the institution where he has dedicated his time, I am thrilled that his work has been recognized in this way.”

“Today is a wonderful day for Dr. Houghton and the faculty,” said Faculty of Medicine & Dentistry dean Brenda Hemmelgarn. “Dr. Houghton has been an amazing colleague and powerful force since the first day he joined us, and we are immensely proud of him and his accomplishments.”

In addition to his role as director of the Li Ka Shing Applied Virology Institute, Houghton is the Li Ka Shing Professor of Virology, and a professor in the Department of Medical Microbiology and Immunology in the Faculty of Medicine & Dentistry.

The Li Ka Shing Institute of Virology was created through a gift of $25 million from the Li Ka Shing (Canada) Foundation, as well as a $52.5-million commitment from the Government of Alberta.

“This is a great day for Canada, the University of Alberta and the Li Ka Shing Institute of Virology,” said Lorne Tyrrell, director of the institute. “Canada’s only Nobel Prize in Physiology or Medicine was won in 1923 by Frederick Banting and John Macleod. The second prize has come 97 years later–a long-awaited Nobel in medicine for a scientist at a Canadian university. I am extremely proud of Michael and his two colleagues, Harvey Alter and Charlie Rice.”

###

Media Contact
Michael Brown
[email protected]

Original Source

https://www.folio.ca/university-of-alberta-virologist-awarded-nobel-prize-in-physiology-or-medicine/

Tags: Clinical TrialsImmunology/Allergies/AsthmaInfectious/Emerging DiseasesInternal MedicineMedicine/HealthVaccines
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

COVID-19 infection in immunodeficient patient cured by infusing convalescent plasma

January 21, 2021
IMAGE

The immune system mounts a lasting defense after recovery from COVID-19

January 21, 2021

Hope for a vaccination against Staphylococcus areus infections?

January 21, 2021

Estrogen receptors in mom’s placenta critical during viral infection

January 21, 2021
Next Post
IMAGE

Lighting the path to recycling carbon dioxide

IMAGE

Seeking ancient rainforests through modern mammal diets

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    54 shares
    Share 22 Tweet 14
  • People living with HIV face premature heart disease and barriers to care

    65 shares
    Share 26 Tweet 16
  • New drug form may help treat osteoporosis, calcium-related disorders

    40 shares
    Share 16 Tweet 10
  • New findings help explain how COVID-19 overpowers the immune system

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Technology/Engineering/Computer ScienceBiologyClimate ChangePublic HealthMaterialsInfectious/Emerging DiseasesMedicine/HealthcancerGeneticsCell BiologyEcology/EnvironmentChemistry/Physics/Materials Sciences

Recent Posts

  • Regulating the ribosomal RNA production line
  • A professor from RUDN University developed new liquid crystals
  • New technique builds super-hard metals from nanoparticles
  • No more needles for diagnostic tests?
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In